3
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Successful Therapy of Viral Keratitis

, M.D.
Pages 518-521 | Published online: 18 Apr 2016

REFERENCES

  • Tamm, I.: Symposium on the experimental pharma cology and clinical use of antimetabolites. III. Metabolic antagonists and selective virus inhibition. Clin. Pharmacol. & Therap. 1: 777, 1960.
  • Magee, W. E.: DNA polymerase and deoxyribo- nucleotide kinase activities in cells infected with vaccinia virus. Virology 17: 604, 1962.
  • Green, M. and Pina, M.: Stimulation of the DNA- synthesizing enzymes of cultured human cells by vaccinia virus infection. Ibid.,2 p. 603.
  • Kit, S. and Dubbs, D. R.: Acquisition of thymidine kinase activity by herpes simplex infected mouse fibroblast cells. Biochem. & Biophys. Res. Communications 2: 55, 1963.
  • Prusoff, W. H.: Synthesis and biological activities of iododeoxyuridine, an analog of thymidine. Biochim. et biophys. acta 32: 295, 1959.
  • Calabresi, P., Cardoso, S. S., Finch, S. C., Kligerman, M. M., Von Essen, C. F., Chu, M. Y. and Welch, A. D.: Initial clinical studies with 5-iodo- deoxyuridine. Cancer Res. 21: 550, 1961.
  • Herrmann, E. C., Jr.: Plaque inhibition test for detection of specific inhibitors of DNA containing viruses. Proc. Soc. Exper. Biol. & Med. 107: 142, 1961.
  • Kaufman, H. E., Maloney, E. D. and Nesburn, A. B.: Comparison of specific anti-viral agents in herpes simplex keratitis. Invest. Ophth. 1: 686, 1962.
  • Corwin, M. E., Okumoto, M., Thygeson, P. and Jawetz, E.: A double blind study of the effect of 5-iodo-2′-deoxyuridine on experimental herpes simplex keratitis. Am. J. Ophth. 55: 225, 1963.
  • Underwood, G. E.: Activity of 1/β-D-arabinofuranosyl- cytosine hydrochloride against herpes simplex keratitis. Proc. Soc. Exper. Biol. & Med. 111: 660, 1952.
  • Kaufman, H. E. and Maloney, E. D.: IDU and CA in herpetic keratitis. Arch. Ophth. 69: 626, 1963.
  • Thygeson, P.: Herpes corneae. (Editorial.) Am. J. Ophth. 36: 269, 1953.
  • Kaufman, H. E., Nesburn, A. B. and Maloney, E. D.: IDU therapy of herpes simplex. Arch. Ophth. 67: 583, 1962.
  • Kaufman, H. E. and Maloney, E. D.: IDU and hydrocortisone in experimental herpes simplex keratitis. Arch. Ophth. 68: 3, 1962.
  • Kaufman, H. E., Martola, E-L. and Dohlman, C. H.: IDU and corticosteroids in herpes simplex keratitis. Ibid.,11 p. 468.
  • Paterson, A., Fox, A. D., Davies, G., Maguire, C., Sellers, P. J. H., Wright, P., Rice, N. S. C, Cobb, B. and Jones, B. R.: Controlled studies of IDU in the treatment of herpetic keratitis. Presented at Oxford Ophthalmological Congress, Oxford, England, July 1963.
  • Kaufman, H. E.: Symposium: Chemotherapy of herpes keratitis. Invest. Ophth. 2: 504, 1963.
  • Calabresi, P., McCollum, R. W. and Welch, A. D.: Inhibitory effects of 5-iodo-2′-deoxyuridine (IUDR) upon infections caused by vaccinia, a DNA virus. Clin. Res. Proc. 10: 397, 1962.
  • Welch, A. D.: Personal communication.
  • Burns, R. P.: A double-blind study of IDU in human herpes simplex keratitis. Arch. Ophth. 70: 381, 1963.
  • Laibson, P. R. and Leopold, I. H.: An evaluation of double-blind IDU therapy in 100 cases of herpetic keratitis. Presented at the American Academy of Ophthalmology and Otolaryngology, October 1963.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.